Director’s Messages

Each person responds to stress in different ways. In this Director’s message, Dr. Gordon talks about managing fear, anxiety, and stress related to the coronavirus pandemic.

In this Director’s Message, Dr. Gordon highlights new findings that advance our understanding of how genetic differences contribute to the development of schizophrenia.

Mental health disparities are significant and easily documented. In this Director’s Message, Dr. Gordon discusses NIMH-funded research that aims to close the gap, ensuring that improved mental health care meets the needs of all Americans.

In this Director’s Message, Dr. Gordon discusses the potential that technology holds for expanding the reach of mental health care.

In this Director’s Message, directed toward a general audience, Dr. Gordon discusses the role of animals in mental health research and what they can tell us about human mental illnesses.

In this Director’s Message, directed toward the research community, Dr. Gordon provides guidance to researchers on the use of animals in mental health research funded by NIMH.

September is National Suicide Prevention Awareness Month. In observance, Dr. Gordon has partnered with Dr. Volkow, Director of the National Institute on Drug Abuse (NIDA), to highlight a dimension of the opioid crisis that receives too little attention—the links between opioid use, opioid use disorder, and suicide.

In his latest message, Dr. Gordon discusses the role of NIMH and other researchers in the development of esketamine, an FDA-approved, rapid-acting medication that targets treatment-resistant depression.

In this Director’s message, Dr. Gordon digs into the historical roots of the hippocampus and the role it plays in human memory – an example of how scientists build upon past research discoveries and, in turn, advance the science that could benefit future generations.

In this Director’s Message, Dr. Gordon discusses research-based advances in the understanding and treatment of depression.